RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Oklahoma City, OK · +62 more sites
Lupus clinical trials in Oklahoma City, OK
11 recruiting lupus studies with a site in Oklahoma City, OK.
RecruitingPhase 2NCT07409181
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Sponsor: Boehringer Ingelheim
Oklahoma City, OK · +29 more sites
RecruitingPhase 3NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Sponsor: AstraZeneca
Oklahoma City, OK · +29 more sites
RecruitingPhase 4NCT06875960
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Sponsor: Bristol-Myers Squibb
Oklahoma City, OK · +3 more sites
RecruitingPhase not listedNCT07175285
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Sponsor: Bristol-Myers Squibb
Oklahoma City, OK · +25 more sites
RecruitingPhase 3NCT05799378
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Sponsor: NYU Langone Health
Oklahoma City, OK · +11 more sites
RecruitingPhase 1NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
Sponsor: GlaxoSmithKline
Oklahoma City, OK · +5 more sites
RecruitingPhase 1NCT06308978
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Sponsor: Fate Therapeutics
Oklahoma City, OK · +15 more sites
RecruitingPhase not listedNCT00198068
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Sponsor: Hospital for Special Surgery, New York
Oklahoma City, OK · +7 more sites
RecruitingPhase 4NCT05559671
Safety of the Herpes Zoster Subunit Vaccine in Lupus
Sponsor: NYU Langone Health
Oklahoma City, OK · +1 more sites
RecruitingPhase 4NCT07225387
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
Sponsor: NephroNet, Inc.
Oklahoma City, OK · +6 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.